Track Tibet Weixinkang Medicine , Ltd.'s receivables ($180M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Tibet Weixinkang Medicine , Ltd. (603676.SS) currently reports a receivables of $180M as of September 2026. That compares with $160M in the prior-year period — up 11.8% year over year. Use the charts on this page to explore Tibet Weixinkang Medicine , Ltd.'s receivables history and peer comparisons.
Tibet Weixinkang Medicine , Ltd.'s receivables increased from $160M to $180M — a 11.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Tibet Weixinkang Medicine , Ltd. reported $180M in receivables as of September 2026. That compares with $160M in the prior-year period — up 11.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tibet Weixinkang Medicine , Ltd., and consider following 603676.SS for alerts when major investors trade the stock.